Refractory Plasma Cell Myeloma Clinical Trials in Scottsdale

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1423 more
2022-04-06
Apr 6, 2022
M
Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib
Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +2 more
2022-03-23
Mar 23, 2022
N
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Active, not recruiting
Has Results
  • DS Stage I Plasma Cell Myeloma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Scottsdale, Arizona
  • +139 more
2022-02-09
Feb 9, 2022
M
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, or T-cell Lymphoma
Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
2022-02-03
Feb 3, 2022
C
Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Active, not recruiting
Has Results
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
2021-08-18
Aug 18, 2021
M
SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma - 2016
Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +2 more
2019-08-29
Aug 29, 2019
M
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma - 2015
Terminated
Has Results
  • Refractory Plasma Cell Myeloma
  • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
2017-09-14
Sep 14, 2017